Product details

By continuing to use our site you consent to the use of cookies as described in our privacy policy unless you have disabled them.
You can change your cookie settings at any time but parts of our site will not function correctly without them.

Abstract

This note explores patterns, trends and rationales behind the outsourcing of services in the pharmaceutical value chain-from drug discovery through development and manufacturing to marketing and sales. It discusses the role and characteristics of Contract Research Organisations (CRO), Contract Manufacturing Organisations (CMOs) and Contract Sales Organisations (CSOs), as well as potential future developments.The note can be used stand-alone; as background reading for cases on outsourcing or cross-organisational project management; or as complement to similar industry notes that showcase parallel developments (eg EMS Industry Note ''IMD-3-0863'').
Location:
Industry:
Other setting(s):
January 2004

About

Abstract

This note explores patterns, trends and rationales behind the outsourcing of services in the pharmaceutical value chain-from drug discovery through development and manufacturing to marketing and sales. It discusses the role and characteristics of Contract Research Organisations (CRO), Contract Manufacturing Organisations (CMOs) and Contract Sales Organisations (CSOs), as well as potential future developments.The note can be used stand-alone; as background reading for cases on outsourcing or cross-organisational project management; or as complement to similar industry notes that showcase parallel developments (eg EMS Industry Note ''IMD-3-0863'').

Settings

Location:
Industry:
Other setting(s):
January 2004

Related